Primary Care Clinics in Sumner, MS Accepting Medicare
4 Primary Care Clinics found. Showing 1 - 4
 Tallachatchie School Based Clinic Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: Friendship Rd, Sumner, MS 38957 Phone: 662-375-8818 Fax: 662-375-8646 |
Cassidy Bayou Medical Clinic Family Medicine Medicare: Medicare Enrolled Practice Location: 2372 Us 49-e, Sumner, MS 38957 Phone: 662-375-9310 |
Sumner Clinic Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 100 N Court St, Sumner, MS 38957 Phone: 662-375-9989 |
Westside Family Medical Clinic Pllc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 2372 Ms Highway 49 East, Sumner, MS 38957 Phone: 662-375-9310 Fax: 662-375-9311 |
News Archive
Exercise can improve musculoskeletal health for breast cancer survivors, say researchers
One year of exercise can ensure steady maintenance of bone density to help prevent fractures. To build and maintain muscle strength, it is best for older breast cancer survivors to follow an ongoing exercise program of resistance and impact training.
Inovio Pharmaceuticals unveils new DNA-based cytokine immune activator
Inovio Pharmaceuticals, Inc. today unveiled that the company has developed a new DNA-based cytokine immune activator, interleukin -33 (IL-33), that in combination with optimized DNA vaccines delivered by electroporation increased the potency and efficacy of the therapeutic response to the DNA vaccines in a preclinical study.
MU researchers find that resveratrol affects dogs' immune systems in different ways
Resveratrol, a compound found commonly in grape skins and red wine, has been shown to have several potentially beneficial effects on health, including cardiovascular health, stroke prevention and cancer treatments. However, scientists do not yet fully understand how the chemical works and whether or not it can be used for treatment of diseases in humans and animals.
Stealthyx Therapeutics and Cancer Research Technology announce co-development partnership for tumour-targeted therapy
Cancer Research Technology (CRT), the specialist oncology development and commercialisation company, and Stealthyx Therapeutics, the disease targeting drug company spin out of Queen Mary, University of London have entered into an agreement to co-develop Stealthyx's proprietary drug delivery platform, Prothyx.
› Verified 5 days ago